Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1b study of GemRIS in recurrent non-muscle-invasive bladder cancer
NL-OMON46132Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of gemcitabine-releasing intravesical system and gemcitabine, sponsored by Johnson & Johnson. Started Jul 2016; status: completed.
02
Drugs
gemcitabine-releasing intravesical systemgemcitabine
Beyond the preview
Go deeper on NL-OMON46132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46132.